Levine James E.
- SEC CIK
- 0001463151
No open-market purchases or sales filed in the past year.
Current role at each company
- KZIA Kazia Therapeutics LtdChief Financial Officeras of Jun 23, 2026
- CRDF Cardiff Oncology, Inc.Chief Financial Officeras of Mar 13, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Levine James E. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CRDF Cardiff Oncology, Inc.
Chief Financial Officer3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 18, 2024 (view filing) | Dec 16-18 | 2 days | Levine James E.Chief Financial Officer | PPurchase | +7.72K | $4.76 | +$36.7K | +12.9%67.7K after | 3 lots |
| Sep 19, 2022 (view filing) | Sep 16 | 3 days | Levine James E.Chief Financial Officer | PPurchase | +30.0K | $1.56 | +$46.8K | +100.0%60.0K after | |
| Sep 13, 2021 (view filing) | Sep 10 | 3 days | Levine James E.Chief Financial Officer | PPurchase | +30.0K | $6.47 | +$194.0K | New position30.0K after | 5 lots |